Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review

Purpose of this review is to systematically assess the effects on voice and speech of advanced head and neck cancer and its treatment by means of chemoradiotherapy (CRT). The databases Medline, Embase and Cochrane were searched (1991–2009) for terms head and neck cancer, chemoradiation, voice and speech rehabilitation. Twenty articles met the inclusion criteria, whereof 14 reported on voice outcomes and 10 on speech. Within the selected 20 studies, 18 different tools were used for speech or voice evaluation. Most studies assessed their data by means of patient questionnaires. Four studies presented outcome measures in more than one dimension. Most studies summarised the outcomes of posttreatment data that were assessed at various points in time after treatment. Except for four studies, pre-treatment measurements were lacking. This and the fact that most studies combined the outcomes of patients with radiated laryngeal cancers with outcome data of non-laryngeal cancer patients impedes an interpretation in terms of the effects of radiation versus the effects of the disease itself on voice or speech. Overall, the studies indicated that voice and speech degenerated during CRT, improved again 1–2 months after treatment and exceeded pre-treatment levels after 1 year or longer. However, voice and speech measures do not show normal values before or after treatment. Given the large-ranged posttreatment data, missing baseline assessment and the lacking separation of tumour/radiation sites, there is an urgent need for structured standardised multi-dimensional speech and voice assessment protocols in patients with advanced head and neck cancer treated with CRT.

[1]  P. Fayers,et al.  Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Dietz,et al.  Organerhalt beim fortgeschrittenen Larynx- bzw. Hypopharynxkarzinom durch primäre Radiochemotherapie Ergebnisse einer multizentrischen Phase-II-Studie , 2002, HNO.

[3]  L. Burkhead,et al.  Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review , 2009, European Archives of Oto-Rhino-Laryngology.

[4]  F. Hilgers,et al.  First‐year quality of life assessment of an intra‐arterial (RADPLAT) versus intravenous chemoradiation phase III trial , 2009, Head & neck.

[5]  Rehan Kazi,et al.  Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. , 2008, International journal of radiation oncology, biology, physics.

[6]  Ingo R Titze,et al.  Biological mechanisms underlying voice changes due to dehydration. , 2002, Journal of speech, language, and hearing research : JSLHR.

[7]  A. Sherman,et al.  Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. , 2004, Archives of otolaryngology--head & neck surgery.

[8]  M. DeLacure,et al.  Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[9]  D. Bless,et al.  An Objective Assessment of Voice Production after Radiation Therapy for Stage I Squamous Cell Carcinoma of the Glottis , 1988, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  Stephen Y Lai,et al.  Head and neck cancer , 2008, Cancer.

[11]  平野 実.  Clinical examination of voice , 1981 .

[12]  J. Buatti,et al.  Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. , 2005, Archives of otolaryngology--head & neck surgery.

[13]  P. Boscolo-Rizzo,et al.  Long‐Term Quality of Life After Total Laryngectomy and Postoperative Radiotherapy Versus Concurrent Chemoradiotherapy for Laryngeal Preservation , 2008, The Laryngoscope.

[14]  L. Wilson,et al.  Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Mukherji,et al.  Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion , 2009, The Laryngoscope.

[16]  P. Dejonckere,et al.  A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques , 2001, European Archives of Oto-Rhino-Laryngology.

[17]  K. Robbins,et al.  Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: Disease control and preservation of organ function , 1999, Head & neck.

[18]  E. Vokes,et al.  Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  P H Dejonckere,et al.  [The voice evaluation protocol of the European Laryngological Society (ELS) -- first results of a multicenter study]. , 2005, Laryngo- rhino- otologie.

[20]  I. Titze,et al.  Dependence of phonatory effort on hydration level. , 1994, Journal of speech and hearing research.

[21]  Jean-Pierre Martens,et al.  Automated Intelligibility Assessment of Pathological Speech Using Phonological Features , 2009, EURASIP J. Adv. Signal Process..

[22]  M. List,et al.  A performance status scale for head and neck cancer patients , 1990, Cancer.

[23]  K. Fung,et al.  Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. , 2005, International journal of radiation oncology, biology, physics.

[24]  D. Kewson,et al.  Functional Outcomes Following Nonsurgical Treatment for Advanced‐Stage Laryngeal Carcinoma , 2003, The Laryngoscope.

[25]  F. Hilgers,et al.  Structured assessment of the consequences of composite resection. , 1998, Clinical otolaryngology and allied sciences.

[26]  N. Sobol,et al.  Preliminary results , 2020, Asymptotic Analysis of Random Walks: Light-Tailed Distributions.

[27]  P. Dejonckere,et al.  Das Stimmdiagnostik-Protokoll der European Laryngological Society (ELS) - erste Erfahrungen im Rahmen einer Multizenterstudie , 2005 .

[28]  G. Funk,et al.  Comprehensive head and neck oncology health status assessment , 2003, Head & neck.

[29]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  S. Fex,et al.  Phoniatric treatment combined with radiotherapy of laryngeal cancer for the avoidance of radiation damage. , 1969, Acta oto-laryngologica. Supplementum.

[31]  E. Weymuller,et al.  Assessment of quality of life in head and neck cancer patients , 1993, Head & neck.

[32]  C. Newman,et al.  The Voice Handicap Index (VHI)Development and Validation , 1997 .

[33]  N. Hogikyan,et al.  Validation of an instrument to measure voice-related quality of life (V-RQOL). , 1999, Journal of voice : official journal of the Voice Foundation.

[34]  Fabrice Denis,et al.  Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. , 2003, International journal of radiation oncology, biology, physics.

[35]  F. Hilgers,et al.  A decade of postlaryngectomy vocal rehabilitation in 318 patients: a single Institution's experience with consistent application of provox indwelling voice prostheses. , 2000, Archives of otolaryngology--head & neck surgery.

[36]  I. V. Verdonck‐de Leeuw,et al.  Health status and voice outcome after treatment for T1a glottic carcinoma , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[37]  D. Kuik,et al.  The efficacy of voice therapy in patients after treatment for early glottic carcinoma , 2006, Cancer.

[38]  A. Rademaker,et al.  Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers , 2001, International journal of cancer.

[39]  I. Nishimoto,et al.  Voice and swallowing in patients enrolled in a larynx preservation trial. , 2003, Archives of otolaryngology--head & neck surgery.

[40]  T. Murry,et al.  Assessing vocal function after chemoradiation for advanced laryngeal carcinoma. , 1996, Archives of otolaryngology--head & neck surgery.

[41]  A. Rademaker,et al.  Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation , 2002, Head & neck.

[42]  H. Bartelink,et al.  Multidimensional Assessment of Voice Characteristics After Radiotherapy for Early Glottic Cancer , 1999, The Laryngoscope.

[43]  J. Schornagel,et al.  Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. , 2002, Archives of otolaryngology--head & neck surgery.

[44]  C. Lazarus.  Effects of chemoradiotherapy on voice and swallowing , 2009, Current opinion in otolaryngology & head and neck surgery.

[45]  H. A. Leeper,et al.  Effects of head and neck radiation therapy on vocal function. , 2001, The Journal of otolaryngology.